A. Tanaka, “Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis”, Acta Derm Venereol, vol. 104, p. adv34375, Sep. 2024.